December 8, 2022 @ 11:00 am – 12:00 pm
China NMPA created several special fast-track registration channels for medical devices. To further encourage innovation, China announced recently that approved innovative products can enjoy special pricing with higher premium enjoy reimbursement and exempt from China Volume-based Purchasing (VBP). China is the 2nd largest MedTech market and the only country with continuous double-digit growth. How can overseas companies benefit from accessing the China market faster with these special pathways?
Innovation is one of the pre-market submission pathways with equal opportunity for both overseas and domestic manufacturers. In addition, there are other special pathways.
This session will address the topics of:
- Overview of green pathways
- Criteria and requirements of innovation pathway
- Innovation special review dossier process
- Advantages and consideration of fast-track channel: traditional vs. innovation pathway
- Benefit of innovative products in VBP, pricing and reimbursement
Free